此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Combined Magnetic Stimulation and Ultrasound for Detrusor Overactivity in SCI

2026年11月9日 更新者:Xue Jiang、Shengjing Hospital

A Randomized, Double-Blind, Sham-Controlled Trial of Sacral Nerve Root High-Frequency Magnetic Stimulation Combined With Ultrasound Therapy for Detrusor Overactivity in Patients With Spinal Cord Injury

This clinical trial aims to investigate whether the combination of high-frequency sacral nerve root magnetic stimulation and bladder-directed ultrasound therapy can effectively improve detrusor overactivity (involuntary bladder contractions) and related voiding dysfunctions in patients with spinal cord injury. The main questions it seeks to answer are:

What is the effect of high-frequency sacral nerve root magnetic stimulation on detrusor overactivity and bladder function in patients with spinal cord injury?

What is the effect of bladder-directed ultrasound therapy on detrusor overactivity and bladder wall compliance in patients with spinal cord injury?

Is the combination of these two treatment modalities superior to magnetic stimulation alone?

研究概览

详细说明

Researchers will combine high-frequency sacral nerve root magnetic stimulation with bladder ultrasound therapy and compare this combination against magnetic stimulation alone (with sham ultrasound) to determine whether the combined approach provides added benefit.

Participants will:

Receive either sacral nerve root magnetic stimulation, bladder ultrasound therapy, or the combination of both, once daily for 3 consecutive weeks (7 sessions per week).

Attend the hospital for urodynamic testing (to assess safe bladder capacity, storage pressure, and compliance) and urinary tract ultrasound (to evaluate bladder wall thickness and upper urinary tract structure) before the treatment and after the 3-week intervention.

Maintain a voiding diary for at least 3 consecutive days (recording single voided volumes, urgency scores, and incontinence episodes), and complete validated questionnaires on lower urinary tract symptoms and quality of life.

研究类型

介入性

注册 (估计的)

44

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

研究联系人备份

学习地点

      • Shenyang、中国
        • 招聘中
        • Rehabilitation Center of Shengjing Hospital, China Medical University, shenyang, Liaoning 110000
        • 接触:
        • 接触:

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 80年 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  1. Diagnosis of spinal cord injury (SCI) above the sacral level according to the International Standards for Neurological Classification of Spinal Cord Injury (revised 2011), confirmed by CT or MRI;
  2. Detrusor overactivity confirmed by urodynamic study;
  3. No severe urinary system diseases such as tumors, stones, infection, or organic urinary tract obstruction;
  4. No severe hepatic/renal insufficiency, pulmonary, or cardiovascular diseases;
  5. Aged 18-80 years;
  6. Able to understand and comply with the required examinations, rehabilitation assessments, and treatment, and provide written informed consent.

Exclusion Criteria:

  1. Unstable vital signs or critically ill condition;
  2. Severe autonomic dysreflexia;
  3. Presence of metallic implants within 10 cm of the magnetic stimulation treatment area;
  4. Any other diseases or conditions that may interfere with the study outcomes.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:双倍的

武器和干预

参与者组/臂
干预/治疗
实验性的:Experimental Group: Sacral Nerve Root Magnetic Stimulation + Active Ultrasound Therapy

Magnetic stimulation: round coil over S3 foramina, verified by toe twitch. 20 Hz intermittent, 1000 pulses/session, intensity 55%-100% max. Active ultrasound: after saline infusion with pressure monitoring (stop at 40 cmH₂O or discomfort), 1.0 MHz, 1.5-2.0 W/cm², 1000 μs PRP, 1:4 duty cycle, 200 μs pulse duration. Probe moved over suprapubic area, 20 min/session. Both given once daily, 7 days/week for 3 weeks. Stop immediately if pressure >40 cmH₂O or any discomfort.

Participants receive the intervention assigned to their group 7 days per week for 3 weeks.

假比较器:Control Group: Sacral Nerve Root Magnetic Stimulation + Sham Ultrasound Therapy

Magnetic stimulation: identical to Arm 1. Sham ultrasound: same probe, same interface settings (frequency, intensity display, pulse parameters) but zero output power. Bladder infusion and pressure monitoring same as Arm 1. Probe moved over suprapubic area for 20 min/session. Treatment frequency and duration identical to Arm 1 (once daily, 7 days/week, 3 weeks). Stop if pressure >40 cmH₂O or discomfort.

Participants receive the intervention assigned to their group 7 days per week for 3 weeks.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Bladder capacity at first detrusor overactivity
大体时间:Baseline and immediately after 3-week intervention

Measured by urodynamic study. The volume at which involuntary detrusor contraction first occurs during bladder filling. Target safe capacity ≥300 ml.

Baseline and immediately after 3-week intervention

次要结果测量

结果测量
措施说明
大体时间
Urodynamic parameters-Bladder compliance
大体时间:Baseline and immediately after 3-week intervention

reflecting bladder wall elasticity, calculated as the change in bladder volume divided by the change in detrusor pressure, ΔV/ΔP

Baseline and immediately after 3-week intervention
Chinese version of the Neurogenic Bladder (NB) Brief Health Survey
大体时间:Baseline and immediately after 3-week intervention

assessing the impact of neurogenic bladder on overall health status and daily living

Baseline and immediately after 3-week intervention
Voiding diary parameters
大体时间:Baseline and after 3-week intervention

Includes single-void volume, urgency score, and incontinence episodes, recorded over at least 72 consecutive hours.

Baseline and after 3-week intervention
Urodynamic parameters-First sensation of bladder filling
大体时间:Baseline and immediately after 3-week intervention

the infused volume at which the subject first perceives the initial urge to void

Baseline and immediately after 3-week intervention
Infection-related indicators-Urine white blood cell (WBC) count
大体时间:Baseline and immediately after 3-week intervention

an objective laboratory quantitative indicator of urinary tract infection

Baseline and immediately after 3-week intervention
Antibiotic utilization rate
大体时间:Baseline and immediately after 3-week intervention

calculated as defined daily doses per treatment cycle, reflecting the frequency of antibiotic intervention due to infection during the treatment period

Baseline and immediately after 3-week intervention
Urodynamic parameters-Detrusor leak point pressure
大体时间:Baseline and immediately after 3-week intervention

the detrusor pressure at the moment of urinary leakage during storage, reflecting urethral closure reserve

Baseline and immediately after 3-week intervention
Urodynamic parameters-Maximum detrusor contraction pressure
大体时间:Baseline and immediately after 3-week intervention

the peak detrusor pressure achieved during the voiding phase

Baseline and immediately after 3-week intervention
Urodynamic parameters-Duration of detrusor contraction
大体时间:Baseline and immediately after 3-week intervention

the total time of sustained effective detrusor contraction during voiding

Baseline and immediately after 3-week intervention
Overactive Bladder Symptom Score (OABSS)
大体时间:Baseline and immediately after 3-week intervention

quantifying the severity of lower urinary tract symptoms including frequency, urgency, and urgency incontinence

Baseline and immediately after 3-week intervention
Voiding difficulty score
大体时间:Baseline and immediately after 3-week intervention

assessing subjective symptoms such as straining, weak stream, and hesitancy

Baseline and immediately after 3-week intervention
Quality of Life score (QoL)
大体时间:Baseline and immediately after 3-week intervention

evaluating the interference of lower urinary tract dysfunction with daily activities, social functioning, and emotional well-being

Baseline and immediately after 3-week intervention
Bladder wall thickness
大体时间:Baseline and immediately after 3-week intervention

measured by ultrasound, reflecting detrusor hypertrophy or fibrotic changes

Baseline and immediately after 3-week intervention
Bladder tissue architecture / morphology
大体时间:Baseline and immediately after 3-week intervention

including wall layering clarity, mucosal surface regularity, and internal echogenicity uniformity

Baseline and immediately after 3-week intervention
Upper urinary tract dilation, pelvicalyceal system separation, and hydronephrosis
大体时间:Baseline and immediately after 3-week intervention

comprehensively assessing the degree of ureteral and pelvicalyceal dilatation as structural indicators of upper urinary tract damage risk

Baseline and immediately after 3-week intervention

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Xue Jiang、Rehabilitation Center of Shengjing Hospital, China Medical University

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2026年7月1日

初级完成 (估计的)

2027年4月30日

研究完成 (估计的)

2027年4月30日

研究注册日期

首次提交

2026年7月6日

首先提交符合 QC 标准的

2026年7月9日

首次发布 (实际的)

2026年7月15日

研究记录更新

最后更新发布 (实际的)

2026年11月10日

上次提交的符合 QC 标准的更新

2026年11月9日

最后验证

2026年7月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅